|
|
|
|
|
by webmobdev
1871 days ago
|
|
The Russian vaccine isn't the only non-mRNA vaccine - India's Covaxin and Oxford / Astrazenaca's Covishield (as it is marketed in India) also doesn't require the kind of cold-storage that the Pfizer or Moderna vaccines do. [1] Interestingly, India's Covaxin also had a similar controversy as Sputnik-V and critics accused it of being hurried and rushed through without going through all the trials: Experts wondered how a vaccine was cleared for emergency use by millions of vulnerable people when its trials were still underway. The All India Drug Action Network at the time said that it was "baffled to understand the scientific logic" to approve "an incompletely studied vaccine". It said that there were "intense concerns arising from the absence of the efficacy data".
Both the manufacturer and drug regulator had defended Covaxin, saying it was "safe and provides a robust immune response" ... Bharat Biotech had said that Indian clinical trial laws allowed "accelerated" authorisation for use of drugs ... It had promised to provide efficacy data for the vaccine by February, which it has now done. [2]
[1][2]: https://www.bbc.com/news/world-asia-india-55748124 |
|